2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides | Arthritis and Rheumatism | 2013 | 3.4K |
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative | Arthritis and Rheumatism | 2013 | 1.6K |
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative | Annals of the Rheumatic Diseases | 2013 | 1.1K |
Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!) | Osteoarthritis and Cartilage | 2013 | 883 |
The epidemiology and impact of pain in osteoarthritis | Osteoarthritis and Cartilage | 2013 | 756 |
EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis | Annals of the Rheumatic Diseases | 2013 | 753 |
Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors | Nature Reviews Rheumatology | 2013 | 525 |
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort | Arthritis and Rheumatism | 2013 | 488 |
A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study | Annals of the Rheumatic Diseases | 2013 | 468 |
The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis | Rheumatology | 2013 | 446 |
A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study | Annals of the Rheumatic Diseases | 2013 | 436 |
Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic study | Arthritis and Rheumatism | 2013 | 402 |
Epidemiology of osteoarthritis | Rheumatic Disease Clinics of North America | 2013 | 392 |
OARSI recommended performance-based tests to assess physical function in people diagnosed with hip or knee osteoarthritis | Osteoarthritis and Cartilage | 2013 | 388 |
Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial | Arthritis and Rheumatism | 2013 | 383 |
Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease | Annals of the Rheumatic Diseases | 2013 | 379 |
EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis | Annals of the Rheumatic Diseases | 2013 | 376 |
Subchondral bone in osteoarthritis: insight into risk factors and microstructural changes | Arthritis Research and Therapy | 2013 | 367 |
Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1) | Annals of the Rheumatic Diseases | 2013 | 347 |
Osteoarthritis as a disease of mechanics | Osteoarthritis and Cartilage | 2013 | 321 |
Cam impingement causes osteoarthritis of the hip: a nationwide prospective cohort study (CHECK) | Annals of the Rheumatic Diseases | 2013 | 307 |
The impact of tumor necrosis factor α inhibitors on radiographic progression in ankylosing spondylitis | Arthritis and Rheumatism | 2013 | 301 |
Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review | Annals of the Rheumatic Diseases | 2013 | 292 |
Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis | Nature Reviews Rheumatology | 2013 | 292 |
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids | Annals of the Rheumatic Diseases | 2013 | 281 |